New cardiotonic drugs
Carlier, J.
Revue Medicale de Liege 32(8): 240-245
1977
ISSN/ISBN: 0370-629X PMID: 866852 Document Number: 122421
Document emailed within 1 workday
Related Documents
Ehara, T. 1974: Cardiotonic effect of various drugs and ions and characteristics of their actions Nihon Seirigaku Zasshi. Journal of the Physiological Society of Japan 36(8-9): 328Utley, J.R.; Michalsky, G.B.; Treat, R.C.; Mobin-Uddin, K.; Perlin, A.R. 1975: Effect of cardiotonic and vasoactive drugs on transmural flow distribution and ventricular volume in the fibrillating heart on cardiopulmonary bypass Circulation 52(2 Suppl): I9-15
Jaillon, P. 1983: New cardiotonic agents Presse Medicale 12(33): 2027-2029
Schoner, W. 2001: Endogenous cardiotonic steroids Cellular and Molecular Biology 47(2): 273-280
Slowińska, J. 1971: Cardiotonic action of glucagon Wiadomosci Lekarskie 24(18): 1747-1752
Andreani, A.; Bossa, R.; Galatulas, I.; Ninci, M.A.; Rambaldi, M. 1991: Reduction of adriamycin cardiotoxicity by a new cardiotonic agent Anticancer Research 11(1): 375-377
Rizvanbegović, B. 1972: Cardiotonic therapy during a course of acute myocardial infarct Medicinski Arhiv 26(2): 101-103
Kondratovich, M.A.; Orlova, N.N. 1976: Mechanism of the cardiotonic effect of alpha-adrenoblockade by phentolamine Kardiologiia 16(12): 116-120
Zisel'man, S.B.; Sivkov, S.I. 1978: Tetrapolar rheography in the study of pharmacodynamics of cardiotonic agents Sovetskaia Meditsina 9: 87-90
Schwartz, A.; Grupp, G.; Wallick, E.; Grupp, I.L.; Ball, W.J. 1988: Role of the Na+K+-ATPase in the cardiotonic action of cardiac glycosides Progress in Clinical and Biological Research 268b: 321-338
Bossa, R.; Aresca, P.; Galatulas, I.; Ninci, M. 1989: Reduction of 4-epiadriamycin cardiotoxicity by milrinone, a new cardiotonic agent Anticancer Research 9(3): 605-608
Grinevich, A.I.; Chekman, I.S.; Roshchupkina, E.V.; Angelutsa, P.A. 1993: The interaction of nonglycoside cardiotonic agents with other drug preparations Kardiologiia 33(6): 56-61
Haegele, K.D.; Hinze, C.; Joder-Ohlenbusch, A.M.; Cremer, G.; Borlak, J. 1991: Effects of a standardized meal on the pharmacokinetics of the new cardiotonic agent piroximone Arzneimittel-Forschung 41(12): 1225-1229
Sun, W.-y.; Tong, L.; Li, D.-x.; Bi, K.-s. 2016: Bioactive consistency evaluation of cardiotonic pill using marker genes Yao Xue Xue Bao 51(8): 1290-1296
Earl, C.Q.; Linden, J.; Weglicki, W.B. 1986: Biochemical mechanisms for the inotropic effect of the cardiotonic drug milrinone Journal of Cardiovascular Pharmacology 8(4): 864-872
Diederen, W.; Weisenberger, H. 1981: Studies on the mechanism of the positive-inotropic action of AR-L 115 BS, a new cardiotonic drug Arzneimittel-Forschung 31(1a): 177-182
Yapo, A.F.; Yapi, H.F.; Bidie, A.d.P.; Abo, K.J.-C.; Otokore, D.A.; Datte, Y.J.; Djaman, A.J. 2011: Comparison of the mechanism of cardiotonic action of the fraction 3 of MAI-BAO and digoxin on rat isolated heart Le Mali Medical 26(2): 49-54
Chekman, I.S.; Poliakova, I.F. 1975: Cardiotonic action of cardiac glycosides and lipid metabolism (literature survey) Vrachebnoe Delo 1975(11): 5-10
Kobayashi, M.; Nakamura, H.; Kobayashi, J.; Ohizumi, Y. 1991: Mechanism of inotropic action of xestoquinone, a novel cardiotonic agent isolated from a sea sponge Journal of Pharmacology and Experimental Therapeutics 257(1): 82-89
Vannier, C.; Lakomkine, V.; Vassort, G. 1997: Tension response of the cardiotonic agent (+)-EMD-57033 at the single cell level American Journal of Physiology 272(5 Pt 1): C1586-C1593